.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
US Department of Justice
Colorcon
Healthtrust
Boehringer Ingelheim
US Army
Moodys
Cantor Fitzgerald
Queensland Health
Fish and Richardson

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020417

« Back to Dashboard

NDA 020417 describes FEMPATCH, which is a drug marketed by Parke Davis and is included in one NDA. Additional details are available on the FEMPATCH profile page.

The generic ingredient in FEMPATCH is estradiol. There are seventy-five drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the estradiol profile page.

Summary for 020417

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 020417

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength0.025MG/24HR
Approval Date:Dec 3, 1996TE:RLD:No

Expired Orange Book Patents for NDA: 020417

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Parke DavisFEMPATCHestradiolFILM, EXTENDED RELEASE;TRANSDERMAL020417-001Dec 3, 1996► Subscribe► Subscribe
Parke DavisFEMPATCHestradiolFILM, EXTENDED RELEASE;TRANSDERMAL020417-001Dec 3, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Medtronic
Chubb
Boehringer Ingelheim
UBS
Colorcon
Accenture
McKesson
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot